Opendata, web and dolomites

AllergyExplorer SIGNED

Automation of novel multi-parameter allergy test that is cost-efficient and delivers instantly correct results

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 AllergyExplorer project word cloud

Explore the words cloud of the AllergyExplorer project. It provides you a very rough idea of what is the project "AllergyExplorer" about.

decision    customer    spent    clearer    declared    recommendations    off    least    21st    tested    trade    quarter    rate    immunological    close    eliminate    substantiates    solution    adequately    manual    automated    experts    pressure    million    asthma    global    clinical    individual    public    optimal    points    registered    vitro    globally    practitioners    union    monopoly    2016    allergen    valuable    estimate    independent    life    device    amounted    automate    de    multiply    anamnesis    allergens    140    diagnosed    profile    market    century    usd    selling    enhanced    revenues    patients    population    health    few    delivering    digit    segments    facto    time    quality    provides    select    complete    bn    expand    allergic    double    lab    approx    half    validated    insufficiently    avoidance    allergies    single    supplier    return    almost    allergy    routine    treatment    jobs    100    medical    diagnostics    molecular    fast    customers    700    labs    prior    instrumentation    technically    immunotherapy    therapeutic    forcing    instead    diagnosis    annual    risk    saved   

Project "AllergyExplorer" data sheet

The following table provides information about the project.

Coordinator
MACROARRAY DIAGNOSTICS GMBH 

Organization address
address: GUTHEIL SCHODER GASSE 17 TECHPARK VIENNA STIEGE 3
city: WIEN
postcode: 1230
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Total cost 3˙536˙250 €
 EC max contribution 2˙475˙375 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MACROARRAY DIAGNOSTICS GMBH AT (WIEN) coordinator 2˙475˙375.00

Map

 Project objective

Allergies and asthma affect at least a quarter of the population and the WHO has declared allergy a major health problem of the 21st century. Currently, medical practitioners must pre-select very few allergens for in-vitro testing, based on prior anamnesis, under time and cost pressure. Independent experts estimate that almost half of the patients are diagnosed insufficiently. The consequences for the patients are not optimal treatment and reduced quality of life. For the public health systems more than 140 Bn Euro are spent each year which could be saved if all allergic patients were treated adequately. We have developed a multi-parameter allergy test covering close to 100% of the globally relevant allergens in a single lab test. Instead of forcing medical practitioners to pre-select very few allergens for in-vitro, our solution substantiates any therapeutic decision by offering a complete immunological profile for every tested individual. We expand testing to the molecular level which provides valuable decision points such as enhanced risk assessment, improving the success of allergen immunotherapy or clearer recommendations for avoidance. We eliminate the trade-off between cost and quality of allergy diagnosis. Our allergy test is technically validated and registered as an in-vitro diagnostics device in Europe. We are already selling and delivering the non-automated manual test systems to customers all over Europe. In this project, we will fully automate the test instrumentation so we can target the customer segments of highly automated clinical routine labs. This will multiply our selling potential and expand our customer reach. The global market of in-vitro diagnosis of allergy is growing fast at almost double-digit rate globally, and amounted to approx. 700 million USD annual revenues in 2016. There is a de-facto monopoly of a single US supplier and this project will return jobs and revenues to the European Union.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ALLERGYEXPLORER" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ALLERGYEXPLORER" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Preemie (2019)

Personalised nutrition of low-birth-weight infants

Read More  

ECOBIOMASS (2019)

Achieving unique wines through an efficient production process

Read More  

ALR4000 (2019)

Automated LCD Recycling series 4000

Read More